| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/03/2009 | WO2009145181A1 Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare using the primer or the probe |
| 12/03/2009 | WO2009144983A1 Inorganic nanoparticle labeling agent |
| 12/03/2009 | WO2009144933A1 Apoptosis inducer |
| 12/03/2009 | WO2009144914A1 G-quadruplex detection method, g-quadruplex dna detection method, and telomerase activity measurement method |
| 12/03/2009 | WO2009144894A1 Biosensor |
| 12/03/2009 | WO2009144881A1 Measurement method, measurement device, and measurement apparatus for creatinine concentration and measurement method, measurement device, and measurement apparatus for amount of salinity using the same |
| 12/03/2009 | WO2009144725A1 Carbon nanotube structures in sensor apparatuses for analyzing biomarkers in breath samples |
| 12/03/2009 | WO2009144702A1 Novel method for diagnosing pregnancy-related complications |
| 12/03/2009 | WO2009144690A1 A method of assessing cancer status in a breast cancer patient |
| 12/03/2009 | WO2009144677A2 Profiles of volatile hydrocarbon compounds, markers of degradation/ageing of cellulosic material and disease markers |
| 12/03/2009 | WO2009144667A1 Monoclonal antibodies having homosubtype cross -neutralization properties against influenza a viruses subtype h1 |
| 12/03/2009 | WO2009144660A1 Device and methods for detecting analytes in saliva |
| 12/03/2009 | WO2009144560A1 Method and device for sample preparation |
| 12/03/2009 | WO2009144507A1 Assay device |
| 12/03/2009 | WO2009144506A1 Assay device |
| 12/03/2009 | WO2009144487A2 Improvements to mass spectrometry |
| 12/03/2009 | WO2009144478A2 Mycobacterial infections |
| 12/03/2009 | WO2009144433A1 Methods for selection of melanocortin 4 receptor-specific agents for treatment of obesity |
| 12/03/2009 | WO2009144432A1 Mc4-r agonists for the treatment of obesity |
| 12/03/2009 | WO2009144307A1 MEANS AND METHODS FOR IDENTIFYING A SUBJECT BEING SUSCEPTIBLE TO A CARDIAC THERAPY BASED ON DETERMINATION OF A CARDIAC TROPONIN, sCD40L AND C-REACTIVE PROTEIN |
| 12/03/2009 | WO2009144304A1 Biosensor, use thereof and method for recording the cell reaction of viable cells |
| 12/03/2009 | WO2009144229A1 Method for risk reduction in glycemic control |
| 12/03/2009 | WO2009144178A1 Device for determining the amount of at least one oxidizable ingredient in an aqueous liquid sample |
| 12/03/2009 | WO2009144176A1 Reaction device for analyzing biological samples and relative method |
| 12/03/2009 | WO2009143935A1 Screening method for agents suitable for prophylaxis and therapy of alzheimer's disease (ad) |
| 12/03/2009 | WO2009143816A1 Method for isolating cells and disease vectors from bodily fluids |
| 12/03/2009 | WO2009143705A1 Screening mehtod for liver x receptor agonists and application thereof |
| 12/03/2009 | WO2009143633A1 Pcsk9 inhibitors and methods of use thereof |
| 12/03/2009 | WO2009143624A1 Methods of diagnosing rejection of a kidney allograft using genomic or proteomic expression profiling |
| 12/03/2009 | WO2009143622A1 Methods of stratifying, prognosing and diagnosing schizophrenia, mutant nucleic acid molecules and polypeptides |
| 12/03/2009 | WO2009143619A1 Methods of treating or preventing obesity and obesity-related hypertension |
| 12/03/2009 | WO2009143614A1 Linezolid resistance mutations in gram-positive bacteria |
| 12/03/2009 | WO2009143604A1 Molecular signature for fibrosis and atrophy |
| 12/03/2009 | WO2009143565A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 12/03/2009 | WO2009143556A1 TREATMENTS FOR EXCITOTOXICITY AND Aß-MEDIATED TOXICITY AND AGE-ASSOCIATED NEURONAL DYSFUNCTION |
| 12/03/2009 | WO2009143555A1 Concentration filtering and analysis of fluids |
| 12/03/2009 | WO2009126380A3 Methods and compositions for highly sensitive detection of molecules |
| 12/03/2009 | WO2009126350A3 Methods and compositions for targeting k63-linked polyubiquitin |
| 12/03/2009 | WO2009126343A9 Oil emulsions and methods for manufacture and use thereof |
| 12/03/2009 | WO2009125386A3 System and method for on-line analysis and sorting of milk coagulation properties |
| 12/03/2009 | WO2009125354A3 Biofilm-based electrochemical sensor device for environmental conditions and method for the detection of environmental conditions using said device |
| 12/03/2009 | WO2009120770A8 A system and method for providing a compositional measurement of a mixture having entrained gas |
| 12/03/2009 | WO2009120249A9 Detection of head and neck cancer using hypermethylated gene detection |
| 12/03/2009 | WO2009115608A3 Uses of reagents in sample collection and cartridge systems |
| 12/03/2009 | WO2009114515A4 Fluorescent dye tracer method for animal feed supplement products |
| 12/03/2009 | WO2009112498A9 Surface attachment |
| 12/03/2009 | WO2009111484A3 Calibration and accuracy check system for a breath tester |
| 12/03/2009 | WO2009111465A3 Comprehensive modeling of the highly networked coagulation-fibrinolysis-inflammatory-immune system |
| 12/03/2009 | WO2009109862A3 S100a6 and/or s100a4 inhibitors for treating cancer |
| 12/03/2009 | WO2009105422A3 Detection system for detecting and measuring metal ions in an aqueous medium |
| 12/03/2009 | WO2009105275A3 Human biomarkers for determining intrinsic b-cell defects |
| 12/03/2009 | WO2009098492A3 Modulation of adenoviral tropism |
| 12/03/2009 | WO2009092697A3 Method and device for supporting properties of an object in a medium |
| 12/03/2009 | WO2009088876A3 Transgenic non-human animals expressing human blood clotting factors |
| 12/03/2009 | WO2009088460A3 Methods of diagnosing latent and active malignancies |
| 12/03/2009 | WO2009066080A3 Self-assembly monolayer, process for preparing it and array made with this monolayer |
| 12/03/2009 | WO2009061345A3 Targeting cdk4 and cdk6 in cancer therapy |
| 12/03/2009 | WO2009039310A3 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment |
| 12/03/2009 | WO2009024775A8 Bilayers |
| 12/03/2009 | WO2008118871A3 Methods of detecting inhibitors of vif-mediated apobec3g degradation and hiv |
| 12/03/2009 | WO2008077191A8 Improved water analysis |
| 12/03/2009 | WO2004018646A9 Conserved and specific streptococcal genomes |
| 12/03/2009 | US20090299948 Identification and monitoring of systemic lupus erythematosus |
| 12/03/2009 | US20090299763 Methods of cell-based technologies |
| 12/03/2009 | US20090299650 Systems and methods for filtering target probe sets |
| 12/03/2009 | US20090299649 Hydropathy Plots and Fourier Analysis with Ellipsoidal Distance Metric |
| 12/03/2009 | US20090299648 Hydropathy Plots and Fourier Analysis with Ellipsoidal Distance Metric |
| 12/03/2009 | US20090299644 System and method for selecting samples from an antibody analysis for display of complete specificity analysis data |
| 12/03/2009 | US20090299643 Computational Analysis Of The Synergy Among Multiple Interacting Factors |
| 12/03/2009 | US20090299642 Method |
| 12/03/2009 | US20090299162 Signal processing for continuous analyte sensor |
| 12/03/2009 | US20090299161 Marker of wound infection |
| 12/03/2009 | US20090299154 Optical sensor device and image processing unit for measuring chemical concentrations, chemical saturations and biophysical parameters |
| 12/03/2009 | US20090299061 Fluorescence assays with improved sensitivity |
| 12/03/2009 | US20090298919 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 12/03/2009 | US20090298912 Arginase II: A Target treatment of aging heart and heart failure |
| 12/03/2009 | US20090298910 Regulation of epigenetic control of gene expression |
| 12/03/2009 | US20090298874 Bacterial atp synthase binding domain |
| 12/03/2009 | US20090298873 Methods of reducing microbial resistance to drugs |
| 12/03/2009 | US20090298778 Peptides Modulating the Activity of Macrophages, Useable for the Treatment of Rheumatoid Arthritis |
| 12/03/2009 | US20090298775 Method of measuring neprilysin activity |
| 12/03/2009 | US20090298771 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 12/03/2009 | US20090298762 Conjugates of biologically active proteins having a modified in vivo half-life |
| 12/03/2009 | US20090298717 Micro-particle array analysis system, micro-particle array kit, and chemical analysis method |
| 12/03/2009 | US20090298716 Composite arrays utilizing microspheres with a hybridization chamber |
| 12/03/2009 | US20090298705 Methods and assays for oversulfated glycosaminoglycans |
| 12/03/2009 | US20090298199 Immunosorbent assay support and method of use |
| 12/03/2009 | US20090298198 Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cells |
| 12/03/2009 | US20090298197 Sers-based methods for detection of bioagents |
| 12/03/2009 | US20090298196 Quantitative measurement method for recombinant protein |
| 12/03/2009 | US20090298195 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 12/03/2009 | US20090298188 Measurement of a dicarboxylate in urine samples as a novel biomarker of kidney damage |
| 12/03/2009 | US20090298187 Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid |
| 12/03/2009 | US20090298186 Method to Assess Stability of Proteins |
| 12/03/2009 | US20090298185 Protein Detection Reagents and Methods with Dyes and Dextrins |
| 12/03/2009 | US20090298184 Polypeptide Markers for the Diagnosis of Prostate Cancer |
| 12/03/2009 | US20090298182 Handheld analyzer for testing a sample |
| 12/03/2009 | US20090298176 siRNA targeting KRAS |
| 12/03/2009 | US20090298161 Surface Treatment |
| 12/03/2009 | US20090298129 Systems and methods for processing samples in a closed container, and related devices |